Calvin Sandra sold TVTX
November 4, 2025 · Form 4 insider transaction
Calvin Sandra sold 67,115 shares of Travere Therapeutics, Inc. at $36.00 per share, a transaction worth $2.42M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
67,115
Price
$36.00
Total value
$2.42M
InsiderCalvin Sandra
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateNovember 4, 2025
Filing dateNovember 6, 2025
Shares owned after48,545
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This sale was made pursuant to a written plan adopted on June 10, 2025, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.